financing

News

Radiopharma firm AdvanCell raises $315m, and other financing...

This week's round-up of private financings in the biotech arena features AdvanCell, alongside Draig, Drug Farm, MindRank AI, and Alchemab.

News

AI specialist Chai Discovery raises $400m

Fresh from an alliance with Novartis, Chai Discovery has raised $400 million in third-round funding for its AI-based molecular design platform.

News

New biotech Avere plots listing via NextCure merger

New biotech Avere has taken a fast-track to becoming a listed company by merging with NextCure and raising $305m for an oral IL-23 drug for psoriasis.

News

Spero snaps up Innovent immunology drug in strategic pivot

Spero has licensed rights to an anti-CD40L antibody developed by China's Innovent, in a $1.1bn deal that signals a shift away from antimicrobial R&D.

News

Bayer gets €3bn from Apollo for contraceptives unit stake

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.

News

Kalohexis chief executive Russell Potterfield

Obesity biotech Kalohexis files confidential IPO

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO.

Radiopharma firm AdvanCell raises $315m, and other financing...

AI specialist Chai Discovery raises $400m

New biotech Avere plots listing via NextCure merger

Spero snaps up Innovent immunology drug in strategic pivot

Bayer gets €3bn from Apollo for contraceptives unit stake

Obesity biotech Kalohexis files confidential IPO

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks